We previously demonstrated that optimal response to neoadjuvant chemotherapy was significantly associated with a decrease in the density of FoxP3+ regulatory T cells in the stroma of human HGSOC tumours.38 As we did not have access to treatment information for patients included in this cohort, we cannot rule it out as a potential confounding factor. This evidence concerns the gene FOXP3 and neoplasm.